Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Genomic and epidemiological monitoring of yellow fever virus transmission potential.

Faria NR, Kraemer MUG, Hill SC, Goes de Jesus J, Aguiar RS, Iani FCM, Xavier J, Quick J, du Plessis L, Dellicour S, Thézé J, Carvalho RDO, Baele G, Wu CH, Silveira PP, Arruda MB, Pereira MA, Pereira GC, Lourenço J, Obolski U, Abade L, Vasylyeva TI, Giovanetti M, Yi D, Weiss DJ, Wint GRW, Shearer FM, Funk S, Nikolay B, Fonseca V, Adelino TER, Oliveira MAA, Silva MVF, Sacchetto L, Figueiredo PO, Rezende IM, Mello EM, Said RFC, Santos DA, Ferraz ML, Brito MG, Santana LF, Menezes MT, Brindeiro RM, Tanuri A, Dos Santos FCP, Cunha MS, Nogueira JS, Rocco IM, da Costa AC, Komninakis SCV, Azevedo V, Chieppe AO, Araujo ESM, Mendonça MCL, Dos Santos CC, Dos Santos CD, Mares-Guia AM, Nogueira RMR, Sequeira PC, Abreu RG, Garcia MHO, Abreu AL, Okumoto O, Kroon EG, de Albuquerque CFC, Lewandowski K, Pullan ST, Carroll M, de Oliveira T, Sabino EC, Souza RP, Suchard MA, Lemey P, Trindade GS, Drumond BP, Filippis AMB, Loman NJ, Cauchemez S, Alcantara LCJ, Pybus OG.

Science. 2018 Aug 31;361(6405):894-899. doi: 10.1126/science.aat7115. Epub 2018 Aug 23.

PMID:
30139911
2.

Co-infection with Zika and Chikungunya viruses associated with fetal death-A case report.

Prata-Barbosa A, Cleto-Yamane TL, Robaina JR, Guastavino AB, de Magalhães-Barbosa MC, Brindeiro RM, Medronho RA, da Cunha AJLA.

Int J Infect Dis. 2018 Jul;72:25-27. doi: 10.1016/j.ijid.2018.04.4320. Epub 2018 May 5.

3.

The spectrum of neuropathological changes associated with congenital Zika virus infection.

Chimelli L, Melo ASO, Avvad-Portari E, Wiley CA, Camacho AHS, Lopes VS, Machado HN, Andrade CV, Dock DCA, Moreira ME, Tovar-Moll F, Oliveira-Szejnfeld PS, Carvalho ACG, Ugarte ON, Batista AGM, Amorim MMR, Melo FO, Ferreira TA, Marinho JRL, Azevedo GS, Leal JIBF, da Costa RFM, Rehen S, Arruda MB, Brindeiro RM, Delvechio R, Aguiar RS, Tanuri A.

Acta Neuropathol. 2017 Jun;133(6):983-999. doi: 10.1007/s00401-017-1699-5. Epub 2017 Mar 22.

PMID:
28332092
4.

Congenital Zika Virus Infection: Beyond Neonatal Microcephaly.

Melo AS, Aguiar RS, Amorim MM, Arruda MB, Melo FO, Ribeiro ST, Batista AG, Ferreira T, Dos Santos MP, Sampaio VV, Moura SR, Rabello LP, Gonzaga CE, Malinger G, Ximenes R, de Oliveira-Szejnfeld PS, Tovar-Moll F, Chimelli L, Silveira PP, Delvechio R, Higa L, Campanati L, Nogueira RM, Filippis AM, Szejnfeld J, Voloch CM, Ferreira OC Jr, Brindeiro RM, Tanuri A.

JAMA Neurol. 2016 Dec 1;73(12):1407-1416. doi: 10.1001/jamaneurol.2016.3720.

PMID:
27695855
5.

Evidence for Transmission of Zika Virus by Platelet Transfusion.

Motta IJ, Spencer BR, Cordeiro da Silva SG, Arruda MB, Dobbin JA, Gonzaga YB, Arcuri IP, Tavares RC, Atta EH, Fernandes RF, Costa DA, Ribeiro LJ, Limonte F, Higa LM, Voloch CM, Brindeiro RM, Tanuri A, Ferreira OC Jr.

N Engl J Med. 2016 Sep 15;375(11):1101-3. doi: 10.1056/NEJMc1607262. Epub 2016 Aug 17. No abstract available.

6.

Lopinavir Resistance Classification with Imbalanced Data Using Probabilistic Neural Networks.

Raposo LM, Arruda MB, de Brindeiro RM, Nobre FF.

J Med Syst. 2016 Mar;40(3):69. doi: 10.1007/s10916-015-0428-7. Epub 2016 Jan 6.

PMID:
26733278
7.

Differential in vitro kinetics of drug resistance mutation acquisition in HIV-1 RT of subtypes B and C.

Cunha RD, Abreu CM, Gonzalez LM, Nijhuis M, de Jong D, Aguiar RS, Afonso AO, Brindeiro RM, Tanuri A.

PLoS One. 2012;7(10):e46622. doi: 10.1371/journal.pone.0046622. Epub 2012 Oct 3.

8.

In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genes.

Bustamante C, Folarin OA, Gbotosho GO, Batista CN, Mesquita EA, Brindeiro RM, Tanuri A, Struchiner CJ, Sowunmi A, Oduola A, Wirth DF, Zalis MG, Happi CT.

J Infect Dis. 2012 Aug 1;206(3):324-32. doi: 10.1093/infdis/jis359. Epub 2012 May 21.

9.

The Brazilian network for HIV-1 genotyping external quality control assurance programme.

Souza DC, Sucupira MC, Brindeiro RM, Fernandez JC, Sabino EC, Inocencio LA, Diaz RS.

J Int AIDS Soc. 2011 Sep 21;14:45. doi: 10.1186/1758-2652-14-45.

10.

CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes.

Muller NG, Alencar R, Jamal L, Hammer J, Sidney J, Sette A, Brindeiro RM, Kalil J, Cunha-Neto E, Moraes SL.

Clin Exp Immunol. 2011 Apr;164(1):90-9. doi: 10.1111/j.1365-2249.2011.04319.x. Epub 2011 Feb 24.

11.

Enhanced Th17 phenotype in uninfected neonates born from viremic HIV-1-infected pregnant women.

Hygino J, Vieira MM, Guillermo LV, Silva-Filho RG, Saramago C, Lima-Silva AA, Andrade RM, Andrade AF, Brindeiro RM, Tanuri A, Guimarães V, de Melo Bento CA.

J Clin Immunol. 2011 Apr;31(2):186-94. doi: 10.1007/s10875-010-9485-3. Epub 2010 Dec 7.

PMID:
21136282
12.

Accumulation of P(T/S)AP late domain duplications in HIV type 1 subtypes B, C, and F derived from individuals failing ARV therapy and ARV drug-naive patients.

Martins AN, Arruda MB, Pires AF, Tanuri A, Brindeiro RM.

AIDS Res Hum Retroviruses. 2011 Jun;27(6):687-92. doi: 10.1089/AID.2010.0282. Epub 2011 Jan 23.

PMID:
21083435
13.

Failure of highly active antiretroviral therapy in reconstituting immune response to Clostridium tetani vaccine in aged AIDS patients.

Andrade RM, Andrade AF, Lazaro MA, Vieira MM, Barros PO, Borner AR, Silva-Filho RG, Santos JO, Brindeiro RM, Tanuri A, Bento CA.

J Acquir Immune Defic Syndr. 2010 May 1;54(1):10-7. doi: 10.1097/QAI.0b013e3181d6003b.

PMID:
20224419
14.

Pseudo-peptides derived from isomannide: inhibitors of serine proteases.

Barros TG, Pinheiro S, Williamson JS, Tanuri A, Gomes M Jr, Pereira HS, Brindeiro RM, Neto JB, Antunes OA, Muri EM.

Amino Acids. 2010 Mar;38(3):701-9. doi: 10.1007/s00726-009-0273-4. Epub 2009 Mar 28.

PMID:
19330426
15.

Enfuvirtide (T-20) resistance-related mutations in HIV type 1 subtypes B, C, and F isolates from Brazilian patients failing HAART.

Oliveira AC, Martins AN, Pires AF, Arruda MB, Tanuri A, Pereira HS, Brindeiro RM.

AIDS Res Hum Retroviruses. 2009 Feb;25(2):193-8. doi: 10.1089/aid.2008.0160.

PMID:
19239358
16.

Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure.

Dumans AT, Barreto CC, Santos AF, Arruda M, Sousa TM, Machado ES, Sabino EC, Brindeiro RM, Tanuri A, Duarte AJ, Soares MA.

Infect Genet Evol. 2009 Jan;9(1):62-70. doi: 10.1016/j.meegid.2008.10.002. Epub 2008 Oct 17.

17.

Drug resistance mutation profile and accumulation kinetics in human immunodeficiency virus-positive individuals infected with subtypes B and F failing highly active antiretroviral therapy are influenced by different viral codon usage patterns.

Waléria-Aleixo A, Martins AN, Arruda MB, Brindeiro RM, Da-Silva RM, Nobre FF, Greco DB, Tanuri A.

Antimicrob Agents Chemother. 2008 Dec;52(12):4497-502. doi: 10.1128/AAC.00820-08. Epub 2008 Oct 6.

18.
19.

Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantification.

Aguiar RS, Costa LJ, Pereira HS, Brindeiro RM, Tanuri A.

Antimicrob Agents Chemother. 2007 Feb;51(2):638-44. Epub 2006 Nov 20.

20.
21.

Biological characterization of human immunodeficiency virus type 1 subtype C protease carrying indinavir drug-resistance mutations.

Gonzalez LM, Aguiar RS, Afonso A, Brindeiro PA, Arruda MB, Soares MA, Brindeiro RM, Tanuri A.

J Gen Virol. 2006 May;87(Pt 5):1303-9.

PMID:
16603533
22.

Impact of nelfinavir resistance mutations on in vitro phenotype, fitness, and replication capacity of human immunodeficiency virus type 1 with subtype B and C proteases.

Gonzalez LM, Brindeiro RM, Aguiar RS, Pereira HS, Abreu CM, Soares MA, Tanuri A.

Antimicrob Agents Chemother. 2004 Sep;48(9):3552-5.

23.

Primary HIV-1 drug resistance in Brazil.

Soares MA, Brindeiro RM, Tanuri A.

AIDS. 2004 Jun;18 Suppl 3:S9-13.

PMID:
15322478
24.

Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance.

Dumans AT, Soares MA, Machado ES, Hué S, Brindeiro RM, Pillay D, Tanuri A.

J Infect Dis. 2004 Apr 1;189(7):1232-8. Epub 2004 Mar 12.

PMID:
15031792
25.

Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive, infected individuals in the army health service of Rio de Janeiro, Brazil.

Pires IL, Soares MA, Speranza FA, Ishii SK, Vieira MC, Gouvêa MI, Guimarães MA, de Oliveira FE, Magnanini MM, Brindeiro RM, Tanuri A.

J Clin Microbiol. 2004 Jan;42(1):426-30.

26.

In vitro hypersusceptibility of human immunodeficiency virus type 1 subtype C protease to lopinavir.

Gonzalez LM, Brindeiro RM, Tarin M, Calazans A, Soares MA, Cassol S, Tanuri A.

Antimicrob Agents Chemother. 2003 Sep;47(9):2817-22.

27.

Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals.

Brindeiro RM, Diaz RS, Sabino EC, Morgado MG, Pires IL, Brigido L, Dantas MC, Barreira D, Teixeira PR, Tanuri A; Brazilian Network for Drug Resistance Surveillance.

AIDS. 2003 May 2;17(7):1063-9.

PMID:
12700457
28.

Synthesis and anti-HIV activity of new C2 symmetric derivatives designed as HIV-1 protease inhibitors.

Peçanha EP, Figueiredo LJ, Brindeiro RM, Tanuri A, Calazans AR, Antunes OA.

Farmaco. 2003 Feb;58(2):149-57.

PMID:
12581781
29.

A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil.

Soares MA, De Oliveira T, Brindeiro RM, Diaz RS, Sabino EC, Brigido L, Pires IL, Morgado MG, Dantas MC, Barreira D, Teixeira PR, Cassol S, Tanuri A; Brazilian Network for Drug Resistance Surveillance.

AIDS. 2003 Jan 3;17(1):11-21.

PMID:
12478065
30.

Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.

Brindeiro PA, Brindeiro RM, Mortensen C, Hertogs K, De Vroey V, Rubini NP, Sion FS, De Sá CA, Machado DM, Succi RC, Tanuri A.

J Clin Microbiol. 2002 Dec;40(12):4512-9.

31.

Sexual transmission of HIV-1 isolate showing G-->A hypermutation.

Caride E, Brindeiro RM, Kallas EG, de Sá CA, Eyer-Silva WA, Machado E, Tanuri A.

J Clin Virol. 2002 Jan;23(3):179-89.

PMID:
11595597
32.

Genetic variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance.

Vicente AC, Agwale SM, Otsuki K, Njouku OM, Jelpe D, Idoko JA, Caride E, Brindeiro RM, Tanuri A.

Virus Genes. 2001 Mar;22(2):181-6.

PMID:
11324755
33.

In vitro activities of a recombinant foot-and-mouth disease virus replicase expressed in Escherichia coli.

Pacheco AB, Brindeiro RM, Soares MA, de-Almeida DF, Tanuri A.

Braz J Med Biol Res. 1992;25(8):761-76.

PMID:
1342607
34.

The N-terminal amino acid sequence is essential for foot-and-mouth disease virus replicase activity.

Pacheco AB, Brindeiro RM, Soares MA, de-Almeida DF, Tanuri A.

Braz J Med Biol Res. 1992;25(7):659-66.

PMID:
1342596
35.

Expression of an active foot-and-mouth disease virus RNA polymerase in Escherichia coli.

Brindeiro RM, Soares MA, Pacheco AB, de-Pontes OH, de-Almeida DF, Tanuri A.

Braz J Med Biol Res. 1991;24(4):359-63.

PMID:
1668400

Supplemental Content

Loading ...
Support Center